Search Results
Baxter Announces U.S. FDA Approval and Launch of Ready-To-Use Cardiovascular Medicine Eptifibatide
Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide. Baxter’s presentation of eptifibatide is the first of its kind available in a flexible container.
Baxter Honored as a 2019 'Top Company for Executive Women' By the National Association for Female Executives
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE). This recognition highlights the company’s efforts to advance women in leadership and foster an inclusive and diverse culture.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on April 1, 2019, to shareholders of record as of March 1, 2019. The indicated annual dividend rate is $0.76 per share of common stock.
Advancing Scientific Research to Improve Outcomes in the ICU
Investigator initiated research helps advance new innovations in critical care
Baxter to Present at the Barclays Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 3:20 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through September 6, 2019.
Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU
NantHealth (NASDAQ: NH), a leader in connected care solutions, and Baxter International Inc. (NYSE:BAX), a global medical products company, today announced that a NantHealth digital health solution is now available to connect Baxter's Prismaflex system to a hospital electronic medical record (EMR).
Baxter to Present at the Raymond James 40th Annual Institutional Investors Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla. on Tuesday, March 5, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:25 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through April 2, 2019.
Baxter Reports 2018 Fourth-Quarter and Full-Year Results
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended Dec. 31, 2018, and provided its financial guidance for 2019.
Baxter to Present at the 8th Annual SVB Leerink Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:30 p.m. Eastern Time. The live webcast of Baxter’s presentation, can be accessed at www.baxter.com and will be available for replay through May 24, 2019.
Baxter Starts U.S. Clinical Trial for On-Demand Peritoneal Dialysis Solution System
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.S. clinical trial for the company’s on-demand peritoneal dialysis (PD) solution generation system. The innovative system is designed to improve the patient experience by making PD solutions in small batches in the patient’s home.